Linda F Stein Gold (Linda Stein Gold, Linda Stein Gold, L Stein Gold, L S Gold)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Topics

Atopic Dermatitis

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

Dermatology and therapy

The Journal of dermatological treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan Ian Silverberg, Andreas Wollenberg, Linda F Stein Gold, James Q Del Rosso, Gil Yosipovitch, Peter A Lio, Y José Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline J Pierce, Helena Agell, Pamela Guglielmini
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Dermatology and therapy 14 (8) (2024)
Jonathan Ian Silverberg, Andreas Wollenberg, Linda F Stein Gold, James Q Del Rosso, Gil Yosipovitch, Peter A Lio, Y José Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline J Pierce, Helena Agell, Pamela Guglielmini
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Dermatology and therapy 14 (8) (2024)
Jonathan Ian Silverberg, Andreas Wollenberg, Linda F Stein Gold, James Q Del Rosso, Gil Yosipovitch, Peter A Lio, Y José Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline J Pierce, Helena Agell, Pamela Guglielmini
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Dermatology and therapy 14 (8) (2024)
Jonathan Ian Silverberg, Andreas Wollenberg, Linda F Stein Gold, James Q Del Rosso, Gil Yosipovitch, Peter A Lio, Y José Manuel Carrascosa, Gaia Gallo, Yuxin Ding, Zhenhui Xu, Marta Casillas, Evangeline J Pierce, Helena Agell, Pamela Guglielmini
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment. Dermatology and therapy (2024)
Andreas Pinter, Linda F Stein Gold, Adam Reich, Lawrence J Green, Morten Praestegaard, Johan Selmer, April W Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra Elkjaer Stallknecht, Paw Trebbien, Matthias Augustin
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30 th EADV Congress 2021. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Andreas Pinter, A Reich, Monika Arenbergerova, Linda F Stein Gold, A Armstrong, L Iversen, M Praestegaard, Matthias Augustin
Randomised Phase 3 trial demonstrating high efficacy, favourable safety, and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Andreas Pinter, Linda F Stein Gold, Adam Reich, Lawrence J Green, Morten Praestegaard, Johan Selmer, April W Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra Elkjaer Stallknecht, Paw Trebbien, Matthias Augustin
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30 th EADV Congress 2021. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Mark G Lebwohl, Emil A Tanghetti, Linda F Stein Gold, James Q Del Rosso, Nelly K Gilyadov, Abby Jacobson
Fixed-Combination Halobetasol Propionate and Tazarotene in the Treatment of Psoriasis: Narrative Review of Mechanisms of Action and Therapeutic Benefits. Dermatology and therapy 11 (4) (2021)
Mark G Lebwohl, Linda F Stein Gold, Kim A Papp, G Han, D M Pariser, T Lin, S Harris, A Jacobson
Long-term safety and efficacy of a fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis: phase 3 open-label study. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (5) (2021)
Linda F Stein Gold, C Paul, R Romiti
Efficacy and safety of fixed-dose combination calcipotriol/betamethasone dipropionate foam for the treatment of psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Andrew Blauvelt, Kenneth B Gordon, Patricia Lee, Jerry Bagel, Howard Sofen, Benjamin Lockshin, Ahmed M Soliman, Ziqian Geng, Tianyu Zhan, Gabriela Alperovich, Linda F Stein Gold
Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis. The Journal of dermatological treatment (2021)
Andreas Pinter, L J Green, J Selmer, M Praestegaard, Linda F Stein Gold, Matthias Augustin, null null
A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis. Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Simon G Danby, Zoe Diana Draelos, Linda F Stein Gold, Amy Cha, Bonnie Vlahos, Laraine Aikman, Paul Sanders, Dan Wu-Linhares, Michael J Cork
Vehicles for atopic dermatitis therapies: more than just a placebo. The Journal of dermatological treatment (2020)